Education
About Us
Working with TipRanks
Follow Us
BioLife Solutions (BLFS)
NASDAQ:BLFS
Total Valuation
BioLife Solutions has a market cap or net worth of $886.79M. The enterprise value is $868.86M.
Market Cap$886.79M
Enterprise Value$868.86M
Share Statistics
BioLife Solutions has 48,300,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding48,300,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
BioLife Solutions’s return on equity (ROE) is -0.03 and return on invested capital (ROIC) is -3.11%.
Return on Equity (ROE)-0.03
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)-3.11%
Return on Capital Employed (ROCE)-0.03
Revenue Per Employee605.12K
Profits Per Employee0.00
Employee Count159
Asset Turnover0.24
Inventory Turnover1.13
Valuation Ratios
The current PE Ratio of BioLife Solutions is ―. BioLife Solutions’s PEG ratio is 2.20.
PE Ratio―
PS Ratio12.00
PB Ratio3.10
Price to Fair Value3.10
Price to FCF108.55
Price to Operating Cash Flow43.59
PEG Ratio2.20
Income Statement
In the last 12 months, BioLife Solutions had revenue of 96.21M and earned -12.13M in profits. Earnings per share was -0.25.
Revenue96.21M
Gross Profit62.12M
Operating Income-12.13M
Pretax Income-12.08M
Net Income-12.13M
EBITDA-9.38M
Earnings Per Share (EPS)-0.25
Cash Flow
In the last 12 months, operating cash flow was 20.11M and capital expenditures -7.31M, giving a free cash flow of 12.80M billion.
Operating Cash Flow20.11M
Free Cash Flow12.80M
Free Cash Flow per Share0.27
Dividends & Yields
BioLife Solutions pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.60
52-Week Price Change-29.17%
50-Day Moving Average22.83
200-Day Moving Average24.09
Relative Strength Index (RSI)31.40
Average Volume (3m)363.00K
Important Dates
BioLife Solutions upcoming earnings date is May 7, 2026, Before Open (Confirmed).
Last Earnings DateFeb 26, 2026
Next Earnings DateMay 7, 2026
Ex-Dividend Date―
Financial Position
BioLife Solutions as a current ratio of 5.23, with Debt / Equity ratio of 4.81%
Current Ratio5.23
Quick Ratio3.92
Debt to Market Cap0.02
Net Debt to EBITDA1.62
Interest Coverage Ratio-4.48
Taxes
In the past 12 months, BioLife Solutions has paid 49.00K in taxes.
Income Tax49.00K
Effective Tax Rate>-0.01
Enterprise Valuation
BioLife Solutions EV to EBITDA ratio is -121.55, with an EV/FCF ratio of 107.13.
EV to Sales11.84
EV to EBITDA-121.55
EV to Free Cash Flow107.13
EV to Operating Cash Flow56.65
Balance Sheet
BioLife Solutions has $88.93M in cash and marketable securities with $17.90M in debt, giving a net cash position of $71.03M billion.
Cash & Marketable Securities$88.93M
Total Debt$17.90M
Net Cash$71.03M
Net Cash Per Share$1.47
Tangible Book Value Per Share$3.33
Margins
Gross margin is 64.56%, with operating margin of -12.61%, and net profit margin of -12.61%.
Gross Margin64.56%
Operating Margin-12.61%
Pretax Margin-12.56%
Net Profit Margin-12.61%
EBITDA Margin-9.74%
EBIT Margin-9.74%
Analyst Forecast
The average price target for BioLife Solutions is $33.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$33.20
Price Target Upside80.83% Upside
Analyst ConsensusStrong Buy
Analyst Count6
Revenue Growth Forecast-18.82%
EPS Growth Forecast92.56%